38 related articles for article (PubMed ID: 36111744)
1. Exploration and validation of a novel ferroptosis-related gene signature predicting the prognosis of intrahepatic cholangiocarcinoma.
Yao X; Chen B; Wang M; Zhang S; He B; Shi Z; Deng T; Bao W; Wang Y; Chen G; Bo Z
Acta Biochim Biophys Sin (Shanghai); 2022 Sep; 54(9):1376-1385. PubMed ID: 36111744
[TBL] [Abstract][Full Text] [Related]
2. [Prediction of prognosis of patients with radical resection of intrahepatic cholangiocarcinoma based on single cell omics].
Chen JL; Tang Y; Qin DL; Li ZL; Tang ZH; Quan ZW
Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):316-323. PubMed ID: 38432673
[No Abstract] [Full Text] [Related]
3. Exploration of a screening model for intrahepatic cholangiocarcinoma patients prone to cuproptosis and mechanisms of the susceptibility of CD274-knockdown intrahepatic cholangiocarcinoma cells to cuproptosis.
Shen Z; Cai J; Tao L; Zheng J; Ye Z; Liu Y; Pan H; Wang Y; Xu J; Liang X
Cancer Gene Ther; 2023 Dec; 30(12):1663-1678. PubMed ID: 37828105
[TBL] [Abstract][Full Text] [Related]
4. Ferroptosis-related gene glutathione peroxidase 4 promotes reprogramming of glucose metabolism via Akt-mTOR axis in intrahepatic cholangiocarcinoma.
Hori Y; Yoh T; Nishino H; Okura K; Kurimoto M; Takamatsu Y; Satoh M; Nishio T; Koyama Y; Ishii T; Iwaisako K; Seo S; Hatano E
Carcinogenesis; 2024 Mar; 45(3):119-130. PubMed ID: 38123365
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a lactate metabolism-related six-gene prognostic signature in intrahepatic cholangiocarcinoma.
Sang C; Yan L; Lin J; Lin Y; Gao Q; Shen X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):199. PubMed ID: 38627278
[TBL] [Abstract][Full Text] [Related]
6. Development of a ferroptosis-based molecular markers for predicting RFS in prostate cancer patients.
Chen J; Zhang L; Luo Y; Tan C; Hu H; Jiang Y; Xi N; Zeng Q; Peng H
Sci Rep; 2023 Dec; 13(1):22804. PubMed ID: 38129557
[TBL] [Abstract][Full Text] [Related]
7. Identification of neutrophil-related genes and development of a prognostic model for cholangiocarcinoma.
Li J; Xiong J; Wei L; Zhang M; Yi J; Liu L
J Gene Med; 2024 Jan; 26(1):e3569. PubMed ID: 37533324
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota regulates the ALK5/NOX1 axis by altering glutamine metabolism to inhibit ferroptosis of intrahepatic cholangiocarcinoma cells.
Zhang Q; Zhou J; Zhai D; Jiang Q; Yang M; Zhou M
Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(5):167152. PubMed ID: 38582012
[TBL] [Abstract][Full Text] [Related]
9. A preliminary study unveils CISD2 as a ferroptosis-related therapeutic target for recurrent spontaneous abortion through immunological analysis and two-sample mendelian randomization.
Shangguan M; Zheng J; Liu N; Zhao J; Wang Q
J Reprod Immunol; 2024 Apr; 163():104249. PubMed ID: 38678819
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Identification of a Ferroptosis-Related Prognostic Signature in Sepsis via Bioinformatics Analyses and Experiment Validation.
International BR
Biomed Res Int; 2024; 2024():9785480. PubMed ID: 38550060
[TBL] [Abstract][Full Text] [Related]
11. High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma.
Zhou Y; Gu Q; Zhu L; Zhang S; Wu H; Pu X; Jiang C; Chen J
Cell Prolif; 2023 Dec; 56(12):e13513. PubMed ID: 37401015
[TBL] [Abstract][Full Text] [Related]
12. Expression of m6A RNA Methylation Regulators and Their Clinical Predictive Value in Intrahepatic Cholangiocarcinoma.
Wei F; Zhang JN; Zhao YQ; Lyu H; Chen F
Front Biosci (Landmark Ed); 2023 Jun; 28(6):120. PubMed ID: 37395024
[TBL] [Abstract][Full Text] [Related]
13. MCM6 promotes intrahepatic cholangiocarcinoma progression by upregulating E2F1 and enhancing epithelial-mesenchymal transition.
Gao C; Li J; Zeng F; Wang L; Chen K; Chen D; Hong J; Qu C
Carcinogenesis; 2023 Jun; 44(4):279-290. PubMed ID: 37185675
[TBL] [Abstract][Full Text] [Related]
14. Establishment and validation of lncRNA-related prognostic signatures in cholangiocarcinoma.
Li F; Zhang J; Zhang J; Xue H; Liu L; Yang Z; Dong H; Wang K
Genomics; 2023 May; 115(3):110621. PubMed ID: 37068643
[TBL] [Abstract][Full Text] [Related]
15. ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma.
Yao W; Liu X; He Y; Tian M; Lu S; Wang Q; Zheng Y; Lv Z; Hao C; Xue D; Meng X
Mol Ther Oncolytics; 2022 Dec; 27():48-60. PubMed ID: 36284715
[TBL] [Abstract][Full Text] [Related]
16. Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Ding L; Ning S; Hu W; Xue Y; Yu S
Oxid Med Cell Longev; 2022; 2022():6595989. PubMed ID: 36199423
[TBL] [Abstract][Full Text] [Related]
17.
Wu J; Guo Y; Zuo ZF; Zhu ZW; Han L
World J Gastroenterol; 2023 May; 29(19):2961-2978. PubMed ID: 37274806
[TBL] [Abstract][Full Text] [Related]
18. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a gene expression-based nomogram to predict the prognosis of patients with cholangiocarcinoma.
Wang W; Wu C; Xu L; Li P; Wang K; Li G; Zhao S; Li Y; Fan X; Wang W; Hu M; Wu J; Xu S
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9577-9586. PubMed ID: 37222808
[TBL] [Abstract][Full Text] [Related]
20. ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma.
Liu S; Fan S; Wang Y; Chen R; Wang Z; Zhang Y; Jiang W; Chen Y; Xu X; Yu Y; Li C; Li X
BMC Cancer; 2023 May; 23(1):444. PubMed ID: 37193981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
